The weak percentage of tyrosinase inhibition obtained with 13a shows that the combination of para and ortho hydroxyl groups is required to get potent tyrosinase inhibitors and subsequently, promising therapeutic agents to treat skin diseases (hyperpigmentation, lentigo, vitiligo and skin cancers) [68]. The gene discussed is TYR; the disease is skin cancer.